INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $443,103 | -48.3% | 12,700 | -17.1% | 0.54% | -51.2% |
| Q3 2022 | $857,000 | +8.1% | 15,320 | 0.0% | 1.11% | +8.6% |
| Q2 2022 | $793,000 | -37.0% | 15,320 | -11.5% | 1.02% | -4.2% |
| Q1 2022 | $1,259,000 | -44.8% | 17,320 | -10.3% | 1.07% | -30.7% |
| Q4 2021 | $2,282,000 | -7.0% | 19,300 | +5.5% | 1.54% | -16.5% |
| Q3 2021 | $2,455,000 | -14.3% | 18,300 | +3.4% | 1.85% | -17.8% |
| Q2 2021 | $2,866,000 | +123.2% | 17,700 | +10.6% | 2.25% | +110.8% |
| Q1 2021 | $1,284,000 | +57.4% | 16,000 | +6.7% | 1.07% | +45.2% |
| Q4 2020 | $816,000 | +156.6% | 15,000 | -6.2% | 0.73% | +147.1% |
| Q3 2020 | $318,000 | +14.8% | 16,000 | +21.2% | 0.30% | +19.8% |
| Q2 2020 | $277,000 | – | 13,200 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 572,950 | $19,990,226 | 5.79% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $39,952,225 | 5.34% |
| MPM BioImpact LLC | 455,238 | $15,883,254 | 4.12% |
| ARK Investment Management | 9,420,782 | $328,691,084 | 2.85% |
| Atlas Venture Associates IX, LLC | 10,000 | $348,900 | 1.74% |
| Ghisallo Capital Management LLC | 250,000 | $8,722,500 | 1.55% |
| Nikko Asset Management Americas, Inc. | 2,976,002 | $103,743,430 | 1.49% |
| Prosight Management, LP | 72,116 | $2,516,127 | 1.37% |
| Rokos Capital Management LLP | 826,063 | $28,391,785 | 1.24% |
| Elmwood Wealth Management, Inc. | 67,899 | $2,368,996 | 1.18% |